Assembly and regulation of the chlorhexidine-specific efflux pump AceI.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 32636271.
- Also identified by DOI 10.1073/pnas.2003271117 and PMC identifier 7382281.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Few antibiotics are effective against <i>Acinetobacter baumannii</i>, one of the most successful pathogens responsible for hospital-acquired infections. Resistance to chlorhexidine, an antiseptic widely used to combat <i>A. baumannii</i>, is effected through the proteobacterial antimicrobial compound efflux (PACE) family. The prototype membrane protein of this family, AceI (<i>Acinetobacter</i> chlorhexidine efflux protein I), is encoded for by the <i>aceI</i> gene and is under the transcriptional control of AceR (<i>Acinetobacter</i> chlorhexidine efflux protein regulator), a LysR-type transcriptional regulator (LTTR) protein. Here we use native mass spectrometry to probe the response of AceI and AceR to chlorhexidine assault. Specifically, we show that AceI forms dimers at high pH, and that binding to chlorhexidine facilitates the functional form of the protein. Changes in the oligomerization of AceR to enable interaction between RNA polymerase and promoter DNA were also observed following chlorhexidine assault. Taken together, these results provide insight into the assembly of PACE family transporters and their regulation via LTTR proteins on drug recognition and suggest potential routes for intervention.
Medical subject headings
- Acinetobacter baumannii
- Anti-Bacterial Agents
- Bacterial Proteins
- Chlorhexidine
- Membrane Transport Proteins